The 17th October issue of the limbic ran a feature on the Robertson et al trial (1) that encouraged use of gabapentin and pregabalin for chronic sciatica. This conclusion is not supported by the trial and conflicts with the other available evidence (2-4). We are concerned that uncritical acceptance of the authors’ conclusion will encourage ...
Already a member?
Enter your email to keep reading.